These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 35927923)
1. Construction of Circadian Clock Signature for Tumor Microenvironment in Predicting Survival for Cutaneous Melanoma. Zeng N; Xia Q; Li Y; Ma L; Cheng Y; Chen Y; Lu Q; Lu Z; Wu D; Luo D Curr Pharm Des; 2022; 28(28):2349-2361. PubMed ID: 35927923 [TBL] [Abstract][Full Text] [Related]
2. The fatty acid-related gene signature stratifies poor prognosis patients and characterizes TIME in cutaneous melanoma. Hua S; Wang W; Yao Z; Gu J; Zhang H; Zhu J; Xie Z; Jiang H J Cancer Res Clin Oncol; 2024 Jan; 150(2):40. PubMed ID: 38279987 [TBL] [Abstract][Full Text] [Related]
3. A Necroptosis-Related Gene Signature to Predict the Prognosis of Skin Cutaneous Melanoma. Xie Y; Xu Z; Mei X; Shi W Dis Markers; 2022; 2022():8232024. PubMed ID: 36438905 [TBL] [Abstract][Full Text] [Related]
4. Analysis on tumor immune microenvironment and construction of a prognosis model for immune-related skin cutaneous melanoma. Wu M; Wang Z; Zhang J Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 May; 48(5):671-681. PubMed ID: 37539569 [TBL] [Abstract][Full Text] [Related]
5. Predicting the clinical outcome of melanoma using an immune-related gene pairs signature. Meng L; He X; Zhang X; Zhang X; Wei Y; Wu B; Li W; Li J; Xiao Y PLoS One; 2020; 15(10):e0240331. PubMed ID: 33031392 [TBL] [Abstract][Full Text] [Related]
6. Identification of a Novel Nomogram to Predict Progression Based on the Circadian Clock and Insights Into the Tumor Immune Microenvironment in Prostate Cancer. Feng D; Xiong Q; Zhang F; Shi X; Xu H; Wei W; Ai J; Yang L Front Immunol; 2022; 13():777724. PubMed ID: 35154101 [TBL] [Abstract][Full Text] [Related]
7. Development and validation of ferroptosis-related lncRNA signature and immune-related gene signature for predicting the prognosis of cutaneous melanoma patients. Xiong K; Wang Z; Hounye AH; Peng L; Zhang J; Qi M Apoptosis; 2023 Jun; 28(5-6):840-859. PubMed ID: 36964478 [TBL] [Abstract][Full Text] [Related]
8. A Comprehensive Prognostic and Immunological Analysis of a Six-Gene Signature Associated With Glycolysis and Immune Response in Uveal Melanoma. Liu J; Lu J; Li W Front Immunol; 2021; 12():738068. PubMed ID: 34630418 [TBL] [Abstract][Full Text] [Related]
9. DNA damage repair-related gene signature predicts prognosis and indicates immune cell infiltration landscape in skin cutaneous melanoma. Liang L; Mai S; Mai G; Chen Y; Liu L Front Endocrinol (Lausanne); 2022; 13():882431. PubMed ID: 35957812 [TBL] [Abstract][Full Text] [Related]
10. Development of an IFNγ response-related signature for predicting the survival of cutaneous melanoma. Hu B; Wei Q; Li X; Ju M; Wang L; Zhou C; Chen L; Li Z; Wei M; He M; Zhao L Cancer Med; 2020 Nov; 9(21):8186-8201. PubMed ID: 32902917 [TBL] [Abstract][Full Text] [Related]
11. Identification and validation of an epithelial mesenchymal transition-related gene pairs signature for prediction of overall survival in patients with skin cutaneous melanoma. Shi Y; Li Z; Zhou Z; Liao S; Wu Z; Li J; Yin J; Wang M; Weng M PeerJ; 2022; 10():e12646. PubMed ID: 35116193 [TBL] [Abstract][Full Text] [Related]
12. Development and validation of an immune gene set-based prognostic signature in cutaneous melanoma. Tian Q; Gao H; Zhao W; Zhou Y; Yang J Future Oncol; 2021 Nov; 17(31):4115-4129. PubMed ID: 34291650 [TBL] [Abstract][Full Text] [Related]
13. Identification of immune-related genes with prognostic significance in the microenvironment of cutaneous melanoma. Qu Y; Zhang S; Zhang Y; Feng X; Wang F Virchows Arch; 2021 May; 478(5):943-959. PubMed ID: 33179141 [TBL] [Abstract][Full Text] [Related]
14. Core immune cell infiltration signatures identify molecular subtypes and promote precise checkpoint immunotherapy in cutaneous melanoma. Zhu Z; Li G; Li Z; Wu Y; Yang Y; Wang M; Zhang H; Qu H; Song Z; He Y Front Immunol; 2022; 13():914612. PubMed ID: 36072600 [TBL] [Abstract][Full Text] [Related]
15. The Identification and Validation of a Robust Immune-Associated Gene Signature in Cutaneous Melanoma. Song LB; Luan JC; Zhang QJ; Chen L; Wang HY; Cao XC; Song NH; Lu Y J Immunol Res; 2021; 2021():6686284. PubMed ID: 33688507 [TBL] [Abstract][Full Text] [Related]
16. A novel immune checkpoint-related seven-gene signature for predicting prognosis and immunotherapy response in melanoma. Tian M; Yang J; Han J; He J; Liao W Int Immunopharmacol; 2020 Oct; 87():106821. PubMed ID: 32731180 [TBL] [Abstract][Full Text] [Related]
17. Using Immune-Related lncRNA Signature for Prognosis and Response to Immunotherapy in Cutaneous Melanoma. Xue L; Wu P; Zhao X; Jin X; Wang J; Shi Y; Yang X; She Y; Li Y; Li C Int J Gen Med; 2021; 14():6463-6475. PubMed ID: 34675614 [TBL] [Abstract][Full Text] [Related]
18. Oncogenic signaling pathway-related long non-coding RNAs for predicting prognosis and immunotherapy response in breast cancer. Li H; Liu H; Hao Q; Liu X; Yao Y; Cao M Front Immunol; 2022; 13():891175. PubMed ID: 35990668 [TBL] [Abstract][Full Text] [Related]
19. Identification and validation of ferroptosis-related lncRNA signature as a prognostic model for skin cutaneous melanoma. Guo S; Chen J; Yi X; Lu Z; Guo W Front Immunol; 2022; 13():985051. PubMed ID: 36248853 [TBL] [Abstract][Full Text] [Related]
20. Identification of a pyroptosis-associated long non-coding RNA signature for predicting the immune status and prognosis in skin cutaneous melanoma. Wu L; Liu G; He YW; Chen R; Wu ZY Eur Rev Med Pharmacol Sci; 2021 Sep; 25(18):5597-5609. PubMed ID: 34604952 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]